FR2335222A1 - Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant - Google Patents

Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant

Info

Publication number
FR2335222A1
FR2335222A1 FR7638152A FR7638152A FR2335222A1 FR 2335222 A1 FR2335222 A1 FR 2335222A1 FR 7638152 A FR7638152 A FR 7638152A FR 7638152 A FR7638152 A FR 7638152A FR 2335222 A1 FR2335222 A1 FR 2335222A1
Authority
FR
France
Prior art keywords
preparation
therapeutic compositions
clavulanic acid
etherified derivatives
etherified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7638152A
Other languages
English (en)
French (fr)
Other versions
FR2335222B1 (da
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Glaxo Laboratories Ltd
Original Assignee
Laboratoires Glaxo SA
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA, Glaxo Laboratories Ltd filed Critical Laboratoires Glaxo SA
Publication of FR2335222A1 publication Critical patent/FR2335222A1/fr
Application granted granted Critical
Publication of FR2335222B1 publication Critical patent/FR2335222B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
FR7638152A 1975-12-17 1976-12-17 Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant Granted FR2335222A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51688/75A GB1573503A (en) 1975-12-17 1975-12-17 Clavulanic acid derivatives

Publications (2)

Publication Number Publication Date
FR2335222A1 true FR2335222A1 (fr) 1977-07-15
FR2335222B1 FR2335222B1 (da) 1982-06-11

Family

ID=10461003

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7638152A Granted FR2335222A1 (fr) 1975-12-17 1976-12-17 Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant

Country Status (10)

Country Link
JP (1) JPS5293792A (da)
AU (1) AU2064576A (da)
BE (1) BE849475A (da)
DE (1) DE2657048A1 (da)
DK (1) DK565676A (da)
FR (1) FR2335222A1 (da)
GB (1) GB1573503A (da)
NL (1) NL7613965A (da)
SE (1) SE7614181L (da)
ZA (1) ZA767496B (da)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364216A1 (fr) * 1976-09-09 1978-04-07 Glaxo Lab Ltd Derives de la clavuline et leur procede de preparation
FR2369281A1 (fr) * 1976-10-30 1978-05-26 Beecham Group Ltd Composes a cycle b-lactame utilisables comme medicaments
FR2372837A1 (fr) * 1976-12-03 1978-06-30 Beecham Group Ltd Nouveaux ethers de l'acide clavulanique, utilisables comme medicaments
FR2373545A1 (fr) * 1976-12-11 1978-07-07 Beecham Group Ltd Procede pour la preparation d'ethers de l'acide clavulanique
FR2383184A1 (fr) * 1977-03-10 1978-10-06 Beecham Group Ltd Procede de preparation d'ethers
WO1997010247A1 (en) * 1995-09-15 1997-03-20 Smithkline Beecham P.L.C. Clavulanic acid derivatives for treating atherosclerosis

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3062347D1 (en) * 1979-08-11 1983-04-21 Beecham Group Plc Process for the preparation of derivatives of clavulanic acid

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364216A1 (fr) * 1976-09-09 1978-04-07 Glaxo Lab Ltd Derives de la clavuline et leur procede de preparation
FR2369281A1 (fr) * 1976-10-30 1978-05-26 Beecham Group Ltd Composes a cycle b-lactame utilisables comme medicaments
FR2372837A1 (fr) * 1976-12-03 1978-06-30 Beecham Group Ltd Nouveaux ethers de l'acide clavulanique, utilisables comme medicaments
FR2373545A1 (fr) * 1976-12-11 1978-07-07 Beecham Group Ltd Procede pour la preparation d'ethers de l'acide clavulanique
FR2383184A1 (fr) * 1977-03-10 1978-10-06 Beecham Group Ltd Procede de preparation d'ethers
WO1997010247A1 (en) * 1995-09-15 1997-03-20 Smithkline Beecham P.L.C. Clavulanic acid derivatives for treating atherosclerosis

Also Published As

Publication number Publication date
SE7614181L (sv) 1977-06-18
JPS5293792A (en) 1977-08-06
GB1573503A (en) 1980-08-28
ZA767496B (en) 1978-02-22
DE2657048A1 (de) 1977-06-23
AU2064576A (en) 1978-06-22
DK565676A (da) 1977-06-18
FR2335222B1 (da) 1982-06-11
BE849475A (fr) 1977-06-16
NL7613965A (nl) 1977-06-21

Similar Documents

Publication Publication Date Title
BE842310A (fr) Derives de la thieno-pyridine, leur procede de preparation et composition therapeutique les contenant
FR2331352A1 (fr) Compositions stables d'erythrocytes, leur procede de preparation et leur application
FR2281340A1 (fr) Derives de l'acide folique, leur procede de preparation et leur application
BE846081A (fr) Nouveaux derives d'amidoximes, leur preparation et compositions en contenant
BE801246A (fr) Nouveaux derives de l'acide quinaldique et leur preparation
FR2321291A1 (fr) Nouveaux derives de l'amino-4 quinoleine, leur preparation et leurs applications therapeutiques
FR2343730A1 (fr) Derives d'acide amidinoformique ou d'acide amidinosulfinique, leur preparation et compositions pharmaceutiques les contenant
FR2335222A1 (fr) Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant
BE878020A (fr) Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
FR2334681A1 (fr) Nouveaux derives de l'acide lysergique et leur preparation
FR2353556A1 (fr) Derives de l'acide clavulanique, leur procede de preparation et leur application en therapeutique
FR2320090A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2310132A1 (fr) 14b-hydroxy-3-desoxycardenolides et analogues de ceux-ci, leur preparation et compositions pharmaceutiques les contenant
BE849177A (fr) Derives thiadiazolyliques de l'acide 7-acylamido-3-cepheme-4-carboxylique et leur preparation
PT65574B (fr) Nouveaux derives de l'oxadiazine-1,2,4 one-5 leur preparation et les compositions les contenant
BE843115A (fr) Compositions pharmaceutiques contenant de la debrycine heterocolloidale et leur procede de preparation
FR2299859A1 (fr) Derives d'acide glycyrrhetinique, leur procede de preparation et leur application
FR2521142B1 (fr) Nouveaux derives n-methanesulfonique de la demethyl-3-o istamycine b, leur preparation et compositions therapeutiques en contenant
FR2283670A1 (fr) Derives d'acides 19,20-bis-nor-prostanoique, leur preparation et compositions pharmaceutiques les contenant
BE863802A (fr) Nouveaux derives d'everninomicine, leur procedes de preparation et compositions pharmaceutiques contenant lesdits derives
FR2293429A2 (fr) Nouveaux derives de l'imino-isoindolinone utilisables comme pigments et leur preparation
FR2308365A2 (fr) Derives de l'hydroxy-9 ellipticine et leur application therapeutique
FR2326180A1 (fr) Derives d'acide oxanilique et leur preparation
BE792515A (fr) Nouveaux derives de l'acide lysergique, leur preparation et leur application comme medicaments
BE860042A (fr) Nouveaux derives de l'acide clavulanique, leur preparation et compositions en contenant.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse